Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Alfa Wassermann and Merckle sign development and marketing agreement for rifaximin

June 12, 1997

Successful phase III trials of Cytolex trigger milestone payment for Magainin

June 11, 1997

Peptidomimetic inhibitors of fungal NMT prepared by Searle

June 10, 1997

Micrologix Biotech enhancin restores activity of vancomycin

June 10, 1997

New antibacterial agents described by Zeneca

June 10, 1997

Generic aciclovir approved by FDA

June 9, 1997

In vitro activity of MEN-10700 assessed

June 5, 1997

3M to launch Aldara next week

June 5, 1997

Interferon Sciences announces distribution agreement for Alferon N Injection

June 3, 1997

Molecular structure of prostaglandins responsible for HSF1 activation elucidated

June 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...